The Albuquerque branch of the United Blood Services system was found to have an unusually high blood donor human T-cell leukemia/lymphoma virus (HTLV) seroprevalence (0.72 per 1,OOO). Many studies investigating HTLV seroprevalence and transmission have assumed that all seropositivity is due to HTLV type I (HTLV-I); recent data dispute this conclusion. W e investigated the high prevalence of HTLV seropositivity in New Mexico by determining whether HTLV-I or HTLV-I1 is predominant in our donors.
Using polymerase chain reaction (PCR) amplification of proviral DNA from peripheral blood. followed by sequencespecific hybridization with oligonucleotide probes to distinguish the two viruses, we demonstrate that 9 of 10 Western blot-confirmed HTLV-seropositive blood donors from New Mexico are infected with HTLV-11. Implications of this finding for donors and the safety of the blood supply are discussed. 0 1990 by The American Society of Hematology.
and -11 is possible now only with viral culture or enzymatic amplification (PCR) of a portion of the proviral genome."." Many studies of HTLV seroprevalence and transmission have simply assumed that HTLV seroreactivity is due to HTLV-I, which has been thought to be the more common of the viruses ~o r 1 d w i d e . l~~~~
Recently, Lee et all' used PCR to demonstrate that 21 of 23 HTLV-seropositive IV drug users (IVDUs) were infected with HTLV-11. Other studies support the notion that IVDUs are frequently infected with HTLV-11. In a serologic study, with no molecular verification of HTLV typing results, 18% of IVDU from Queens, N Y were found infected with HTLV-11, compared with 9% with HTLV-I." In another study of New York IVDUs, 19 of 169 (1 1%) were infected with HTLV-11, including seven who were conifected with HTLV-I.I6 Moreover, one recent study showed that 3 of 7 blood donors from diverse US coastal cities were infected with HTLV-11, rather than HTLV-I.I7 Distinction between HTLV-I and -11 has prognostic significance for the infected individual, as well as epidemiologic importance. The relatively large number of blood donors who are presently being found seropositive for HTLV will need to be notified of their infection; such considerations stress the importance of developing reliable and simple procedures for distinguishing the two viruses.
The largest study of HTLV seroprevalence in blood donors published to date found an average prevalence of Westernblot confirmed HTLV infection of 0.25 per 1,000 (although Los Angeles was found to have a rate of 1 per l,000).'4 A similar rate of 0.27 per 1,000 was found in the United Blood Services (UBS) system of blood banks, concentrated in the western and midwestern United States. Donors to the Albuquerque branch of UBS have a higher HTLV-positivity rate (0.72 per 1,000). Initial investigations were undertaken to determine whether HTLV-I or HTLV-I1 was predominant in our population. We modified the procedure used by Lee et ai" by following the suggestion of other^''^'^ that using hybridization probes to regions of the provirus lying between the PCR primers is a reliable way to detect the presence of specific amplification products. Using oligonucleotide probes specific for the amplified portion of the HTLV-I or HTLV-I1 tax gene, we established a "dot-blot" procedure to distinguish the two viruses. In this report we demonstrate that the use of stringent wash conditions allows these primers to selectively (IO'-fold preference) bind to their exact complemen1 at the expense of the mismatched homolog, allowing determination of the type of virus infecting each of IO seropositive blood donors. We found that 9 of IO of our HTLV-positivedonors were infected with HTLV 11. Oligonucleotide primers and probcs. Oligonucleotide primers with sequences as described by Lee et all' (Genetic Designs, Houston, TX) were prepared and purified. Thew primm match with nearly perfect complementarity both HTLV-I and -11. and thus produce PCR amplification products from both viruses." We named these primers 53HT (5' CGGATACCCAGTCTACGT 3') and 35HT (5' GAGCCGATAACGCGTCCATCG 3').
MATERIALS AND METHODS

Mononuclear
Oligonuclwtide probes were choxn to comspond to portions of the amplified product that have undergone maximal change between HTLV-I and HTLV-II. The degree of divergencc of the HTLV-Ispecific probe. HTl(5' TACAAGGCGACTGGTGCCCCAT 3'). and the HTLV-II proviral sequence is 5 out of 22 basepairs (bp). The HTLV-II specific probe, HTII. has the sequence 5' TACAGGC-CGATTGGTGTCCCGT 3' . PCR conditions were as described" except that 50 pmol. rather than 100 pmol. of each G e m f c DNA.
PCR. blotting. and hybddfzatlm. Prehybridization was in standard conditio& for I to I 2 hours at 37% or 42%. Hybridization was identical to pnhybridization excepl that S'-end-labeled oligonuclwtide probes H T l or H T l l (specific activity lo" to IO' cpm/pmol with .I-['*P]-ATP)~ w m added to a final concentration of lo" cpm/mL. The same specific activity of HTI and H T l l probes were always used in sidaby-side hybridizations: when labeling reactions produced direrent specific activities. unlabeled probe was added to the higher specific activity probe to produce identical specific activities. All hybridizations were performed overnight a1 37% to 42%.
Wash conditions were chosen to maximize the specificity of annealing between probes HTI and HTll and their respective proviral complements. F i l t m w m r i d for I to 2 minutes in 6X saline sodium citrate (SSC) at OOC four tima. then washed in 6X SSC at 70% for I minute with shaking. then airdried. and subjected to autoradiography (2 to 24 hours) with intensifying screens at -70%. 
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hybridization of PCR products from the infected cell lines MT4 (HTLV-I) and Mo (HTLV-II) and uninfected cell DNA (PBL) with probes HTI and HTII. It isclear from this figure that sequence-specific probes readily allow the distinction between the two integrated proviral DNAs.
In Fig I B the signal produced from 2 pg of M o DNA (far left panel) is compared with the signal obtained from serial IO-fold dilutions of MT4 DNA samples. using the HTI probe. The intensity of hybridization of 0.2 ng of MT4 DNA (fifth panel) was comparable with that produced by 2 pg of Mo DNA, suggesting that the oligonucleotide-specific probes detected their perfectly matched complement at a IO'-fold lower concentration (of input DNA), compared with mismatched sequences.
Sensitivity of PCR detection of HTLVs. Figure IB demonstrates that HTLV-I sequences can be amplified from as little as 0.2 ng of genomic DNA from the infected cell line MT4. Assuming that no episomal HTLV-I DNA is present in this preparation, and that HTLV-I is present in a single copy per diploid genome. then it appears that the primer pair we used can detect as little as 30 molecules of HTLV proviral DNA.
Optimization of conditions for specific detection of HTL V-I and HTLV-11. In Fig 2 we examined the effect of increasing the number of PCR cycles from 35 to 45 on an HTLV-positive blood donor (determined to be positive for HTLV-II by previous PCR analysis). The number of PCR cycles was varied while keeping other factors constant. This experiment demonstrates that the degree of discrimination between HTLV-I-and HTLV-Il-specific hybridization was improved by increasing the cycle number. with the maximum discrimination becoming apparent at 40 to 45 cycles.
Use Fig 3) . Nine of the IO donors' DNAs had HTLV-II sequences. with only one having HTLV-I. All but one sample was available in sufficient quantity to replicate the hybridization results. Negative control spots were prepared with any of four different DNAs from uninfected persons in each experiment. Four of the donors' amplification products were also tested for the appearance of a band on an ethidium bromide-stained agarose gel of the appropriate size (159 bp); all four produced the predicted band (data not shown). although nonspecific products were also apparent in donors' and negative control DNAs.
Verification of HTLV-I or -11 infection by second PCR procedure. Because PCR has a high potential for false positive diagnoses. we used a second PCR procedure to confirm the diagnoses rendered by the tax primer pair (data not shown). The combination of HTLV-I pol-specific primers SK54 and SK55 with HTLV-I specific probe SK56 was found to produce an amplification product only with DNA from the donor determined to have HTLV-I infection by the 53HT/35HT primer pair." We also confirmed the 53HT/ 35HT viral typing result in a majority (six) of our nine donors diagnosed with HTLV-II. We found the SK58/59 primers were less sensitive in our hands than were the 53HT/35HT primers, in that two donors' DNA samples did not produce amplification product with the SK58/59 primer set. One HTLV-II-positive DNA was not available in sufficient quantity for confirmation.
DISCUSSION
A method for HTLV typing in seropositive donors and patients. We describe the use of oligonucleotide hybridization probes to detect HTLV-I-or -11-specific sequences of an amplified domain common to both proviruses. A similar technique has been used by Kwok et al." but the sensitivity of primers described by that group when applied to patient peripheral blood mononuclear cells (PBMCs) is not known.
This assay was able to allow assignment of virus type to O u r finding that 9 of IO HTLV-seropositive donors were infected with HTLV-II. usually considered to be the more rare of the two HTLVs, is in agreement with the results of Lce et al," and supports the hypothesis that HTLV-I1 infection is more frequent in the United States than previously reoognited.""' Distinction of the two virus types should be performed in other regions with high seroprevalence.
